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trial fibrillation (AF) is the most common complication
ssociated with coronary artery bypass graft (CABG) sur-
ery. The impact of postoperative AF on hospital resources
s substantial, with annual estimated U.S. expenditures
xceeding $1 billion (1) and length of hospital stays in-
reased by a distressing three to four days in the presence of
F (2–4). As a result, postoperative AF represents the most
mportant potentially reversible health care expenditure
elated to CABG in the U.S., contributing to the cost
urden of the “epidemic of AF” (5). Nevertheless, despite
ignificant advances in surgical care, AF incidence stub-
ornly remains around 20% to 40%, although this is due, in
art, to a somewhat-older population of patients undergo-
ng CABG.
See page 994
Atrial fibrillation clusters tightly in the first two to four
ays after surgery. Why? In part, this is the result of
reexisting electrophysiologic vulnerability in the atria, as
videnced by atrial conduction abnormality (6), but atrial
schemia and reperfusion injury, acute atrial stretch, meta-
olic derangements, pericarditis, and heightened sympa-
hetic tone (7) may also be contributing factors. Together,
he presence of preoperative electrical and structural abnor-
ality with the superimposed postoperative profibrillatory
ilieu make a volatile mix and foments a high but short-
erm AF risk.
Pharmacologic therapies have not succeeded in effectively
ddressing this postoperative problem. For example, a
ecent meta-analysis (8) concluded that beta-blockers, so-
alol, and amiodarone all reduce the incidence of postoper-
tive AF. The beneficial impact on hospital length of stay,
owever, was small (by less than one-half day), with no
vidence of a lowering of stroke events (8). Given these
esults, it may be advantageous to develop a more complete
nderstanding of why patients with AF are hospitalized
onger. Surprisingly, this issue has not been extensively
tudied, but it is likely to be multifactorial in causation.
lthough it may be supposed that complications of postop-
rative AF drive the duration of hospitalization, multivariate
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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ork, New York.nalyses have indicated that the simple presence of AF,
djusting for confounding variables, including major com-
lications, is associated with an increased length of stay (9).
n fact, our own data from a retrospective series of 292
atients suggests that the vast majority of AF events are
elatively innocuous, that is, short-lived (only 37% exceeded
4 h or needed cardioversion) and unassociated with symp-
oms (only 11% had any symptoms) (10).
If postoperative AF is generally clinically self-limited and
ncomplicated, why is it associated with such a substantially
onger length of hospital stay? To a large extent, it may be
he result of therapeutic interventions, such as drug initia-
ion and titration, the development of drug side effects, the
ncomplete effectiveness of treatment, and attempts to
chieve therapeutic anticoagulation.
If so, it might be worth developing a prospective trial to
etermine whether length of stay is reduced by a contem-
orary strategy that foregoes aggressive routine antiarrhyth-
ic drug prophylaxis and concentrates instead on reactive
ate-control, cardioversion, and anticoagulants for stroke
revention. These treatments are all readily accomplishable
n the outpatient environment. This management approach
ould be augmented by the routine use of beta-blockers, if
ot contraindicated, and the use of low-molecular-weight
eparin as a bridge to warfarin therapy (11). A simplified
trategy also has been proposed by others (3,12). Also
romising is the use of atrial pacing to prevent AF after
ardiac surgery (13), but the published experience is still
ather small. In addition, radiofrequency ablation of pulmo-
ary vein triggers has had remarkable success for nonpost-
perative AF, but it is unknown whether a surgical epicar-
ial approach coupled to the routine CABG procedure
ould be effective and safe nor whether pulmonary vein
riggers are important in the postoperative setting.
In this context, the study by Cummings et al. (14) in this
ssue of the Journal is refreshing and provocative. In patients
ndergoing CABG, the authors set out to study the anterior
at pad, located in the aortopulmonary window, which is
outinely removed during the process of placing the aortic
ross-clamp, the aortic cannula for cardiopulmonary bypass,
nd aortic grafts. Because the fat pad contains nervous
issue, the study sought to determine whether it contained
arasympathetic ganglia, as previously described in dogs
15,16), and whether its dissection would decrease subse-
uent AF. Because enhanced vagotonia is profibrillatory in
he atria by shortening refractoriness, the underlying as-
umption was that by removing tissue responsible for vagal
trial influences, an improved AF outcome would result.
he autonomic nervous system has long been thought to
lay a role in AF after cardiac surgery but mediated by an
nhanced adrenergic state. The importance of the parasym-
athetic nervous system has not received much attention in
his setting, although it is known to play a role in subsets of
atients with paroxysmal nonpostoperative AF (17).
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ighly sensitive to vagal influences. Vagal postganglionic
eurons are located in distinct anatomic fat pads, distributed
round the heart and adjacent structures. The fat pad
ocated between the right pulmonary veins and right atrium
ontains fibers that predominantly influence the sinus node,
nd the fat pad located between the inferior vena cava and
he left atrium contains fibers that largely modulate AV
odal function. Elegant experimental work has recently
lucidated the functional importance of a third “anterior” fat
ad: it either serves as a “head station,” distributing fibers to
he sinus and AV nodes and to both atria (15), or as a
modulator” of atrial electrical and contractile function (16).
elective destruction of this fat pad during animal experi-
ents produced complete or partial vagal denervation of the
ight atrium, left atrium, or both, although with variable
onsistency (15). If complete biatrial denervation can be
ccomplished in experimental models, sustained AF can be
revented (15,18).
In the study by Cummings et al. (14), the anterior fat pad
as localized in 55 patients undergoing CABG. Stimula-
ion of the fat pad resulted in sinus rate slowing, with no
hange in PR-interval, indicating a direct or indirect inner-
ation of the sinus node but not the AV node. When the fat
ad was dissected, the vagal effect on sinus rate was lost.
nfortunately, a critical examination of the effect on atrial
efractoriness during stimulation of the anterior fat pad was
ot performed. This leaves open the question of whether
his fat pad influences atrial electrophysiology in humans,
hat is, refractoriness, and in which atrium. Indeed, patho-
ogic confirmation of the neural components of this fat pad
lso was not undertaken.
Patients were then randomized into two groups, one in
hom the anterior fat pad was dissected (as is typical in
ABG) and one in whom the fat pad was deliberately
reserved. The authors anticipated an antiarrhythmic effect on
F when the fat pad was removed; however, the opposite was
bserved: 11 of 29 patients (37%) with a dissected anterior fat
ad developed AF compared with only 2 of the 26 patients
7%) with a preserved anterior fat pad (p 0.01). Importantly,
nly the dissected fat pad group had clinically significant AF.
The study was small and will clearly need confirmation
efore the findings can be considered conclusive. The
tudy’s findings may simply be the play of chance. Interest-
ngly, a previous study has provided a measure of replication
n that anterior fat pad preservation also decreased AF
ncidence (19). Support for the authors’ findings can also be
ound in the literature (20,21) that reports a lower incidence
f AF after off-pump CABG, during which the anterior fat
ad is often preserved. It is, however, important to account
or the generally lower-risk profile of patients who undergo
ff-pump CABG, which would contribute to a lower AF
isk (22).
If the results of the present study are confirmed in future
nvestigation, it could have important implications for
olving the aforementioned costly and hospital lengtheningffects associated with postoperative AF. Notably, this
urgical approach is reputed to be in no way disadvantageous
o the performance of CABG itself. Accordingly, pending
urther confirmation, these results illustrate how a relatively
nnocuous surgical maneuver can have unforeseen important
onsequences.
The current study also raises a series of intriguing
uestions. First, why did removal of the anterior fat pad
rove proarrhythmic? As the authors suggest, it may be that
he balance of sympathetic and parasympathetic regulation
as upset with loss of the anterior fat pad. Alternatively, as
eterogeneity of refractoriness is so important in promoting
eentry as the mechanism of AF, it is quite possible that
eterogenous loss of atrial innervation (partial denervation)
23), which may result if the anterior fat pad was removed,
ggravates a critical determinant of AF.
The data of Cummings et al. (14) suggest that partial
enervation is disadvantageous, at least after cardiac surgery.
nimal experiments endorse complete vagal denervation as
n effective antiarrhythmic strategy (18). Should all three fat
ads be dissected, rather than only one, when CABG or
ther cardiac surgery is performed? Is complete denervation
ore effective than preserved innervation? Do outcomes
iffer for postoperative AF versus nonpostoperative AF? Is
igh vagal tone a prerequisite for antivagal strategies, or are
ll patients at risk of AF sensitive to therapeutic, inadver-
ent, or pathologic modulation of cholinergic neural con-
rol? Are there important detrimental effects on sinus node
r AV node function, or other autonomic cardiac responses,
hen fat pads are removed? More investigative work in the
aboratory and in the operating room is required to address
ach of these issues.
In summary, the mechanisms of AF continue to be
nraveled, often in unexpected ways. The importance of
agal influences and the cardiac fat pads on postoperative
F deserves extensive additional clinical research to deter-
ine the most optimal surgical technique and best overall
ultidisciplinary antiarrhythmic strategies. Although this
ew road may represent the path to finally solving the
billion-dollar” problem of resistant AF after coronary
ypass surgery, it must now face the test of repeated trials.
eprint requests and correspondence: Dr. Jonathan S. Stein-
erg, Chief, Division of Cardiology, St. Luke’s-Roosevelt Hospital
enter, 1111 Amsterdam Avenue, New York, New York 10025.
-mail: jss7@columbia.edu.
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